This indicator tracks the proportion of women who have given birth in the two years prior to the survey and who received preventive antimalarial treatment during their pregnancy, specifically focusing on those who were administered two or more doses of SP/Fansidar. Monitoring this metric is critical, as it provides insights into maternal healthcare practices and the effectiveness of public health initiatives aimed at reducing malaria-related complications in pregnancy. An elevated percentage suggests better access to essential prenatal care, while a lower percentage may indicate gaps in healthcare provision or awareness. Ultimately, this data serves as a key benchmark for evaluating both maternal and child health outcomes, informing strategies to enhance safe pregnancy practices in malaria-endemic regions.
Source: